Brief: HLS Therapeutics Licenses And Files 'Athelas One' Point-Of-Care Device
14/03/2019 10:42
March 14 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS LICENSES AND FILES 'ATHELAS ONE'
POINT-OF-CARE
DEVICE
* HLS THERAPEUTICS INC - HAS IN-LICENSED EXCLUSIVE CANADIAN
RIGHTS
FOR ATHELAS ONE DEVICE
Source text for Eikon: ID:nCNWLwh5ra
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group